untitled
|
|
- まれあ わにべ
- 5 years ago
- Views:
Transcription
1 R Network Meta-Analysis
2 R Network Meta-Analysis homogeneity consistency Ranking Network Meta-Analysis(homogeneity) (consistency) Ranking 1
3 Network Meta-Analysis Network Meta-Analysis P Ranking R Bayesian Network Meta-Analysis 2
4 Network Meta-Analysis Meta-Analysis 2 Network Meta-Analysis Multiple Treatments Comparison Mixed Treatments Comparison 3 3
5 Network Meta-Analysis Network Meta-Analysis Meta-Analysis Network Meta-Analysis I. II. homogeneity consistency III. IV I II R 4
6 Network Meta-Analysis Network Meta-Analysis Network Meta-Analysis 3 multi-arm study Network A vs. B A vs. C B vs. C + A vs. D A B C D 5
7 Network Meta-Analysis Incomplete Block Design Sequence Incomplete Block Design IBD Period A B Patient 11,...,1n 1 2 B A Patient 21,...,2n 2 3 C B Patient 31,...,3n 3 4 B C Patient 41,...,4n 4 Network Meta-Analysis NMA 1: A vs. B Study 11,...,1n 1 IBD A B B C A C B A C GLM MIXED A 2: B vs. C Study 21,...,2n 2 B C 6
8 Network Meta-Analysis Incomplete Block Design Network Meta-Analysis NMA Incomplete Block Design IBD Senn et al IBD Sequence Sequence NMA IBD 1 NMA IBD NMA transitivity consistency 7
9 Network Meta-Analysis Network Meta-Analysis homogeneity consistency Ranking Bayesian Network Meta-Analysis B Treatment Mean Diff. 95% CI A D A B C D [-1.94; -1.57] [-0.61; -0.19] [-1.15; -0.74] C
10 Network Meta-Analysis homogeneity heterogeneity transitivity similarity Network Meta-Analysis Network Meta-Analysis effect modifier consistency Network Meta-Analysis consistency inconsistency 9 Caldwell (2014) Krahn (2013)
11 Network Meta-Analysis Network Meta-Analysis P Ranking R Bayesian Network Meta-Analysis 10
12 Senn2013 Senn et al. (2013) Senn et al. (2013) multi-arm study 1 10 acarbose benfluorex metformin miglitol pioglitazone rosiglitazone sitagliptin sulfonylurea alone vildagliptin placebo HbA1c % Senn2013 studlab treat1 1 treat2 2 TE HbA1c % TREAT1 TREAT2 sete TE 11
13 Senn2013 metf 1 benf migl 1 1 acar piog vild plac 2 1 sulf 6 rosi 1 sita multi-arm Willms
14 Senn2013 TE sete treat1 treat2 studlab metf sulf Alex rosi plac Baksi acar plac Costa rosi plac Davidson metf plac DeFronzo piog rosi Derosa vild plac Garber metf plac Gonzalez-Ortiz piog metf Hanefeld sita plac Hermansen migl plac Johnston migl plac Johnston1998a migl plac Johnston1998b rosi plac Kerenyi rosi metf Kim piog plac Kipnes metf plac Lewin benf plac Moulin acar sulf Oyama rosi plac Rosenstock benf plac Stucci rosi sulf Vongthavaravat acar metf Willms metf plac Willms acar plac Willms rosi plac Wolffenbuttel rosi metf Yang rosi plac Zhu
15 Senn2013 ID TE sete treat1 treat2 studlab s d metf sulf Alex acar plac Costa metf plac DeFronzo metf plac Gonzalez-Ortiz acar metf Willms metf plac Willms acar plac Willms acar metf sulf Senn metf vs. plac 3 multi-arm 1 3 ID=5 plac 14
16 Network Meta-Analysis 1 2 metf acar sulf plac metf % [-1.10, -0.43] % [-0.60, -0.14] % [-1.88, -1.40] acar 0.76 % [ 0.42, 1.10] 0.39 % [-0.02, 0.80] % [-1.14, -0.62] sulf 0.37 % [ 0.14, 0.60] % [-0.80, 0.02] % [-1.61, -0.94] plac 1.64 % [ 1.40, 1.88] 0.88 % [ 0.62, 1.14] 1.27 % [ 0.94, 1.61] Treatment metf acar sulf plac Mean Diff % -0.88% -1.27% 95% CI [-1.88, -1.40] [-1.14, -0.62] [-1.61, -0.94] [95%, 95% ]
17 Network Meta-Analysis, Cov, diag,,,,, plac 1,,5 1,,4 metf acar sulf V 1 V 4 V 5 Y 1 Y 4 Y 5 Willms metf acar plac M A P ID=6 SETE Var(M-P) = Var(M) + Var(P) - 2Cov(M,P) ID=5 ID=7 Cov(M-P, A-P) = Cov(M,A) Cov(M,P) Cov(P,A) +Var(P) 16
18 Network Meta-Analysis 1-step Network Estimate: 1.64, 0.88, step metf acar sulf, Cov Direct Estimate:,,,, Cov, diag,,, Network Estimate: 1.64, 0.88, 1.27 X 1 X 3 X 4 17
19 Network Meta-Analysis,Cov,,Cov 1,,5 1,,4 DerSimonian and Laird Cov 18 multi-arm τ /2 ID=5(acar vs. metf)
20 homogeneity consistency heterogeneity Within-designs Q statistic, inconsistency Between-designs Q statistic, / heterogeneity
21 P Ranking Cov( ) Ranking metf metformin P 1. metf p,,,, 2. P : 1, metf metformin P Ranking P P Bayesian Network Meta-Analysis SUCRA Surface Under the Cumulative RAnking 20 Rucker G and Schwarzer G (2015)
22 Network Meta-Analysis > # 1-step > y <- matrix(c(-0.37, -0.8, -1.9, -0.4, -1.2, -1), ncol=1) > X <- matrix(c(1, 0, -1, 0, 1, 0, 1, 0, 0, 1, 0, 0, 1, 0, 0, 0, 1, 0), ncol=3, by=t) > V <- matrix(c( , 0, 0, 0, 0, 0, + 0, , 0, 0, 0, 0, + 0, 0, , 0, 0, 0, + 0, 0, 0, , 0, 0, + 0, 0, 0, 0, , , + 0, 0, 0, 0, , ), ncol=6, by=t) > ( theta <- solve(t(x) %*% solve(v) %*% X) %*% t(x) %*% solve(v) %*% y ) [,1] [1,] [2,] [3,] > ( Cov <- solve(t(x) %*% solve(v) %*% X) ) [,1] [,2] [,3] [1,] [2,] [3,] > ( theta_ci <- cbind(theta-qnorm(0.975)*sqrt(diag(cov)), + theta+qnorm(0.975)*sqrt(diag(cov))) ) [,1] [,2] [1,] [2,] [3,]
23 Network Meta-Analysis > # 2-step > theta_dir <- matrix(rep(0, 5), ncol=1) > Xa <- X[c(1, 2, 3, 5, 6),] > Va <- matrix(rep(0,25), ncol=5) > theta_dir[1,1] <- sum(solve(v[1,1]) %*% y[1]) * V[1,1]; Va[1,1] <- V[1,1] > theta_dir[2,1] <- sum(solve(v[2,2]) %*% y[2]) * V[2,2]; Va[2,2] <- V[2,2] > theta_dir[3,1] <- sum(solve(v[3:4,3:4]) %*% y[3:4]) / sum(diag(solve(v[3:4,3:4]))) > Va[3,3] <- 1/sum(diag(solve(V[3:4,3:4]))) > theta_dir[4:5,1] <- y[5:6]; Va[4:5,4:5] <- V[5:6,5:6] > ( theta_a <- solve(t(xa) %*% solve(va) %*% Xa) %*% t(xa) %*% solve(va) %*% theta_dir ) [,1] [1,] [2,] [3,] > ( Cov_a <- solve(t(xa) %*% solve(va) %*% Xa) ) [,1] [,2] [,3] [1,] [2,] [3,] > ( theta_ci_a <- cbind(theta-qnorm(0.975)*sqrt(diag(cov_a)), + theta+qnorm(0.975)*sqrt(diag(cov_a))) ) [,1] [,2] [1,] [2,] [3,]
24 Network Meta-Analysis > # Qnet, Qhet, Qinc > ( Q_net <- t(y - X %*% theta) %*% solve(v) %*% (y-x %*% theta) ) [,1] [1,] > ( Q_inc <- t(theta_dir - Xa %*% theta_a) %*% solve(va) %*% (theta_dir - Xa %*% theta_a) ) [,1] [1,] > ( Q_het <- Q_net - Q_inc ) [,1] [1,] > # P score for metf > CC <- -1*diag(3); CC[,1] = 1; E <- CC %*% theta; z <- rep(0,3) > for (i in 1:3) { + c <- CC[i,,drop=F] + z[i] <- sqrt(t(c %*% theta) %*% solve(c %*% Cov %*% t(c)) %*% (c %*% theta)) + if (E[i] < 0) z[i] <- -1*z[i] + } > p_metf <- 1-(pnorm(z)) > ( pscore_metf <- mean(p_metf) ) [1]
25 inconsistency Detaching a single design inconsistency Krahn 2013 Detaching a single design, 1, 0, Cov 1 0 detach, 24
26 inconsistency Detaching a single design,,,,,,,,,,,, 0,,,,, 0 inconsistency, 0 inconsistency 25
27 inconsistency network estimate plac:metf_ plac:acar:metf plac:acar plac:metf plac:acar_ plac:acar:metf plac:metf_ plac:acar:metf direct estimate plac:acar plac:metf plac:acar_ plac:acar:metf (inconsistency) direct estimate network estimate Network estimate 26
28 inconsistency plac:metf_ plac:acar:metf Detach plac:acar plac:metf plac:acar_ plac:acar:metf Detach plac:metf_ plac:acar:metf plac:acar plac:metf plac:acar_ plac:acar:metf = inconsistent evidence = supportive evidence 27
29 inconsistency Detach plac:metf_ plac:acar:metf plac:acar plac:metf plac:acar_ plac:acar:metf plac:metf_ plac:acar:metf Detach plac:acar plac:metf plac:acar_ plac:acar:metf multi-arm metf vs. plac inconsistency metf vs. plac network estimate direct estimate metf vs. plac 3 2-arm 2 metf vs. plac 3 inconsistency 28
30 Network Meta-Analysis Network Meta-Analysis P Ranking R Bayesian Network Meta-Analysis 29
31 Network Meta-Analysis netmeta() netmeta(te, sete, treat1, treat2, studlab, data=senn2013, sm, level=0.95, level.comb=0.95, comb.fixed=true, comb.random=true, reference="", seq=null, title="",...) data TE sete treat1 treat2 studlab sm TE RD Risk Difference RR Risk Ratio OR Odds Ratio MD Mean Difference SMD Standardized Mean Difference IRR Incidence Rate Ratio IRD Incidence Rate Difference level level.comb pooled estimate comb.fixed comb.random reference reference="plac" seq title 30
32 Network Meta-Analysis # install.packages("netmeta", dep=t) library(netmeta) data(senn2013) options(width=1000) x <- netmeta(te, sete, treat1, treat2, studlab, data=senn2013, sm="md", comb.fixed=true, comb.random=true) d1 <- decomp.design(x) # Q d2 <- netmeta:::decomp.tau(x, tau=x$tau) # Q r2 <- netrank(x, small="good") # P forest(x, pooled='fixed') # Forest Plot() forest(x, pooled='random') # Forest Plot() netgraph(x, thickness='se.fixed'); title('fixed Effect Model') # () netgraph(x, thickness='se.random'); title('random Effect Model') # () netheat(x, random=f); mtext('fixed Effect Model', 1, 1, cex=1.8) # Heatmap ( ) netheat(x,random=t,tau=x$tau); mtext('random Effect Model',1,1,cex=1.8) #( ) x$te.random <- x$te.fixed; x$pval.random <- x$pval.fixed r1 <- netrank(x, small="good") # P ( small="good" or "bad" 31
33 Network Meta-Analysis x$te.fixed x$lower.fixed x$upper.fixed x$te.random x$lower.random x$upper.random d1$q.decomp Q homogeneity / consistency d1$q.het.design Design-specific decomposition of within-designs Q statistic d1$q.inc.detach Between-designs Q statistic after detaching of single designs d1$xxx 3 d2$q.decomp d2$q.het.design d2$q.inc.detach Q r1$pscore r2$pscore Network Ranking / 32
34 Network Meta-Analysis x <- netmeta(te, sete, treat1, treat2, studlab, data=senn2013, sm="md", comb.fixed=true, comb.random=true, reference="plac", seq=c('plac', 'acar', 'benf', 'metf', 'migl', 'piog','rosi', 'sita', 'sulf', 'vild')) # reference reference="plac" seq 33
35 Network Meta-Analysis > x$te.fixed # acar benf metf migl piog plac rosi sita sulf vild acar benf metf migl piog plac rosi sita sulf vild > x$lower.fixed # acar benf metf migl piog plac rosi sita sulf vild acar benf metf migl piog plac rosi sita sulf vild > r2$pscore # P acar benf metf migl piog plac rosi sita sulf vild
36 Network Meta-Analysis metf:sulf rosi:sulf metf:piog plac:piog plac:rosi plac:metf metf:rosi piog:rosi plac:acar_plac:acar:metf plac:metf_plac:acar:metf acar:sulf plac:acar Forest Plot 35 metf:sulf rosi:sulf metf:piog plac:piog plac:rosi plac:metf metf:rosi piog:rosi plac:acar_plac:acar:metf plac:metf_plac:acar:metf acar:sulf plac:acar Fixed Effect Model inconsistency multi-arm Willms1999
37 Network Meta-Analysis acar:sulf plac:acar_plac:acar:metf plac:metf plac:acar metf:rosi piog:rosi plac:metf_plac:acar:metf plac:rosi metf:piog plac:piog metf:sulf rosi:sulf Forest Plot acar:sulf plac:acar_plac:acar:metf plac:metf plac:acar metf:rosi piog:rosi plac:metf_plac:acar:metf plac:rosi metf:piog plac:piog metf:sulf rosi:sulf inconsistency 36 Random Effect Model multi-arm Willms1999
38 Arm-based Contrast-based Study Treatment1 y1 sd1 n1 Treatment2 y2 sd2 n2 Treatment3 y3 sd3 n NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TE sete treat1 treat2 studlab contrast-based format arm-based format 37 Dias et. al. (2013) Parkinson
39 Arm-based Contrast-based pairwise(treat, event, n, time, mean, sd, TE, sete, data, studlab,...) treat 1 2 event n time mean sd TE sete data studlab 38 treat n mean sd
40 Arm-based Contrast-based Parkinson > data(parkinson) > p <- pairwise(list(treatment1, Treatment2, Treatment3), + n=list(n1, n2, n3), + mean=list(y1, y2, y3), + sd=list(sd1, sd2, sd3), + data=parkinson, studlab=study) > p TE sete studlab treat1 treat2 n1 mean1 sd1 n2 mean2 sd
41 Arm-based Contrast-based 2 data(smokingcessation) p1 <- pairwise(list(treat1, treat2, treat3), event=list(event1, event2, event3), n=list(n1, n2, n3), data=smokingcessation, sm="rr") 2 p2 <- pairwise(list(treat1, treat2, treat3), event=list(event1, event2, event3), n=list(n1, n2, n3), data=smokingcessation, sm="or") 2 treat event n 40 sm="rd"
42 Arm-based Contrast-based data(dietaryfat) p3 <- pairwise(list(treat1, treat2, treat3), list(d1, d2, d3), time=list(years1, years2, years3), studlab=id, data=dietaryfat, sm="ird") p4 <- pairwise(list(treat1, treat2, treat3), list(d1, d2, d3), time=list(years1, years2, years3), studlab=id, data=dietaryfat, sm="irr") treat time event 41
43 Network Meta-Analysis Network Meta-Analysis P Ranking R Bayesian Network Meta-Analysis 42
44 Bayesian Network Meta-Analysis Bayesian Network Meta-Analysis gemtc Network Meta-Analysis gemtc 1. JAGS JAGS exe 2. R LANGUAGE=en 3. install.packages(c("rjags","gemtc"), dep=t) gemtc > install.packages(c("rjags","gemtc"), dep=t) # > Sys.setlocale(locale="C") # locale US [1] "C" > # Sys.setlocale(locale="Japanese_Japan.932") # locale > plot.new() # History Recording ON > library(gemtc) WinBUGS 43
45 Bayesian Network Meta-Analysis > data <- read.table(textconnection(' + study treatment diff std.err + Alex1998 metf Alex1998 sulf NA NA... + Zhu2003 rosi Zhu2003 plac NA NA'), head=t) # Senn2013 > network <- mtc.network(data.re=data) > plot(network) > summary(network) $Description [1] "MTC dataset: Network" $`Studies per treatment` acar benf metf migl piog plac rosi sita sulf vild $`Number of n-arm studies` 2-arm 3-arm 25 1 $`Studies per treatment comparison` t1 t2 nr 1 acar metf 1 2 acar plac 2 3 acar sulf rosi sulf 1 44
46 Bayesian Network Meta-Analysis > # > model.fe <- mtc.model(network, linearmodel='fixed', likelihood='normal',link='identity') > result.fe <- mtc.run(model.fe, n.adapt=1000, n.iter=5000) > plot(result.fe) > gelman.diag(result.fe) # > summary(result.fe) Results on the Mean Difference scale Iterations = 1:5000 Thinning interval = 1 Number of chains = 4 Sample size per chain = Empirical mean and standard deviation for each variable, plus standard error of the mean: Mean SD Naive SE Time-series SE d.acar.metf d.acar.plac d.acar.sulf d.plac.benf d.plac.migl d.plac.piog d.plac.rosi d.plac.sita d.plac.vild
47 Bayesian Network Meta-Analysis > # > model.fe <- mtc.model(network, linearmodel='fixed', likelihood='normal',link='identity') > result.fe <- mtc.run(model.fe, n.adapt=1000, n.iter=5000) > plot(result.fe) > gelman.diag(result.fe) # > summary(result.fe) 2. Quantiles for each variable: 2.5% 25% 50% 75% 97.5% d.acar.metf d.acar.plac d.acar.sulf d.plac.benf d.plac.migl d.plac.piog d.plac.rosi d.plac.sita d.plac.vild Model fit (residual deviance): Dbar pd DIC data points, ratio 3.926, I^2 = 75% > forest(relative.effect(result.fe, t1="plac")) > ranks <- rank.probability(result.fe, preferreddirection=-1) > plot(ranks) 46
48 Bayesian Network Meta-Analysis > ranks Rank probability; preferred direction = -1 [,1] [,2] [,3] [,4] [,5] [,6] [,7] [,8] [,9] [,10] acar benf metf migl piog plac rosi sita sulf vild
49 Bayesian Network Meta-Analysis Bayesian Network Meta-Analysis 48
50 Bayesian Network Meta-Analysis > # > model.re <- mtc.model(network, linearmodel='random', likelihood='normal',link='identity') > result.re <- mtc.run(model.re, n.adapt=1000, n.iter=5000) > plot(result.re) > gelman.diag(result.re) > summary(result.re) > forest(relative.effect(result.re, t1="plac")) > # DIC > result.fe$deviance$dic [1] > result.re$deviance$dic [1] > # Node-splitting Inconsistency > result.ns <- mtc.nodesplit(network, linearmodel='random', n.adapt=500, n.iter=2000) > plot(result.ns) > summary.ns <- summary(result.ns) > plot(summary.ns) > summary.ns 49
51 Bayesian Network Meta-Analysis Bayesian Network Meta-Analysis 50
52 Network Meta-Analysis Network Meta-Analysis P Ranking R Bayesian Network Meta-Analysis 51
53 Network Meta-Analysis Network Meta-Analysis R homogeneity consistency Ranking Bayesian Network Meta-Analysis 52
54 Caldwell DM (2014) An overview of conducting systematic reviews with network meta-analysis. Systematic Reviews, 3:109. Dias S, Sutton AJ, Ades AE and Welton NJ (2013) Evidence synthesis for decision making 2: A generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Medical Decision Making, 33, Higgins JPT, Jackson D, Barrett JK, Lu G, et. al. (2012) Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Research Synthesis Methods, 3(2), pages Hutton B, Salanti G, Caldwell DM, Chaimani A, et. al. (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Annals of Internal Medicine, 162(11): Krahn U, Binder H and Konig J (2013) A graphical tool for locating inconsistency in network meta analyses. BMC Medical Research Methodology, 13:35. 53
55 Mills EJ, Thorlund K and Ioannidis JP (2013) Demystifying trial networks and network meta-analysis. BMJ. May14; 346:f2914. DerSimonian R and Laird N (1986) Meta-analysis in clinical trials. Controlled Clinical Trials 7: Rucker G, Schwarzer G, Krahn U and Konig J (2014) Netmeta: network meta-analysis with R. R package (version 0.8-0). Rucker G and Schwarzer G (2015) Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Medical Research Methodology, 15:58. Senn S, Gavini F, Magrez D, and Scheen A (2013) Issues in performing a network meta-analysis. Statistical Methods in Medical Research, 22 (2), Gert van Valkenhoef, and Joel Kuiper (2015) Gemtc: Network Meta-Analysis Using Bayesian Methods (Version 0.7-1). 54
56 2016/8/3
57 Backup Slides 2016/8/3
58 Q homogeneity consistency
59 Windows R CRAN R R exe 58
60 Windows R OK (N) > 59
61 Windows R 1. Message translations 2. PC 64-bit 64-bit Files 32-bit Files 32-bit Files (N) > 60
62 Windows R SDI 61
63 Windows R (N) > 62
64 Windows R R or 63
65 Windows R R R install.packages("netmeta", dep=t) Japan (Tokyo) OK R 64
untitled
SAS 2016 SAS Network Meta-Analysis SAS Network Meta-Analysis homogeneity consistency Ranking Network Meta-Analysis(homogeneity) (consistency) Ranking 1 Network Meta-Analysis Network Meta-Analysis P Ranking
More informationNetwork Meta-Analysis
SAS ユーザー総会 2016 SAS での Network Meta-Analysis の実施例 ~ 頻度論に基づくアプローチ ~ 武田薬品工業株式会社日本開発センター生物統計室舟尾暢男 黒田晋吾 要旨 SAS による Network Meta-Analysis の実施方法として 均質性 (homogeneity) や一致性 (consistency) の評価 各薬剤の Ranking の算出方法を含めて紹介する
More informationMicrosoft Word - StatsDirectMA Web ver. 2.0.doc
Web version. 2.0 15 May 2006 StatsDirect ver. 2.0 15 May 2006 2 2 2 Meta-Analysis for Beginners by using the StatsDirect ver. 2.0 15 May 2006 Yukari KAMIJIMA 1), Ataru IGARASHI 2), Kiichiro TSUTANI 2)
More information/22 R MCMC R R MCMC? 3. Gibbs sampler : kubo/
2006-12-09 1/22 R MCMC R 1. 2. R MCMC? 3. Gibbs sampler : kubo@ees.hokudai.ac.jp http://hosho.ees.hokudai.ac.jp/ kubo/ 2006-12-09 2/22 : ( ) : : ( ) : (?) community ( ) 2006-12-09 3/22 :? 1. ( ) 2. ( )
More informationこんにちは由美子です
Sample size power calculation Sample Size Estimation AZTPIAIDS AIDSAZT AIDSPI AIDSRNA AZTPr (S A ) = π A, PIPr (S B ) = π B AIDS (sampling)(inference) π A, π B π A - π B = 0.20 PI 20 20AZT, PI 10 6 8 HIV-RNA
More information一般化線形 (混合) モデル (2) - ロジスティック回帰と GLMM
.. ( ) (2) GLMM kubo@ees.hokudai.ac.jp I http://goo.gl/rrhzey 2013 08 27 : 2013 08 27 08:29 kubostat2013ou2 (http://goo.gl/rrhzey) ( ) (2) 2013 08 27 1 / 74 I.1 N k.2 binomial distribution logit link function.3.4!
More informationkubostat2015e p.2 how to specify Poisson regression model, a GLM GLM how to specify model, a GLM GLM logistic probability distribution Poisson distrib
kubostat2015e p.1 I 2015 (e) GLM kubo@ees.hokudai.ac.jp http://goo.gl/76c4i 2015 07 22 2015 07 21 16:26 kubostat2015e (http://goo.gl/76c4i) 2015 (e) 2015 07 22 1 / 42 1 N k 2 binomial distribution logit
More information12/1 ( ) GLM, R MCMC, WinBUGS 12/2 ( ) WinBUGS WinBUGS 12/2 ( ) : 12/3 ( ) :? ( :51 ) 2/ 71
2010-12-02 (2010 12 02 10 :51 ) 1/ 71 GCOE 2010-12-02 WinBUGS kubo@ees.hokudai.ac.jp http://goo.gl/bukrb 12/1 ( ) GLM, R MCMC, WinBUGS 12/2 ( ) WinBUGS WinBUGS 12/2 ( ) : 12/3 ( ) :? 2010-12-02 (2010 12
More informationRによる計量分析:データ解析と可視化 - 第3回 Rの基礎とデータ操作・管理
R 3 R 2017 Email: gito@eco.u-toyama.ac.jp October 23, 2017 (Toyama/NIHU) R ( 3 ) October 23, 2017 1 / 34 Agenda 1 2 3 4 R 5 RStudio (Toyama/NIHU) R ( 3 ) October 23, 2017 2 / 34 10/30 (Mon.) 12/11 (Mon.)
More informationkubostat2017e p.1 I 2017 (e) GLM logistic regression : : :02 1 N y count data or
kubostat207e p. I 207 (e) GLM kubo@ees.hokudai.ac.jp https://goo.gl/z9ycjy 207 4 207 6:02 N y 2 binomial distribution logit link function 3 4! offset kubostat207e (https://goo.gl/z9ycjy) 207 (e) 207 4
More information1 Stata SEM LightStone 4 SEM 4.. Alan C. Acock, Discovering Structural Equation Modeling Using Stata, Revised Edition, Stata Press 3.
1 Stata SEM LightStone 4 SEM 4.. Alan C. Acock, 2013. Discovering Structural Equation Modeling Using Stata, Revised Edition, Stata Press 3. 2 4, 2. 1 2 2 Depress Conservative. 3., 3,. SES66 Alien67 Alien71,
More information1 Stata SEM LightStone 3 2 SEM. 2., 2,. Alan C. Acock, Discovering Structural Equation Modeling Using Stata, Revised Edition, Stata Press.
1 Stata SEM LightStone 3 2 SEM. 2., 2,. Alan C. Acock, 2013. Discovering Structural Equation Modeling Using Stata, Revised Edition, Stata Press. 2 3 2 Conservative Depress. 3.1 2. SEM. 1. x SEM. Depress.
More informationこんにちは由美子です
1 2 . sum Variable Obs Mean Std. Dev. Min Max ---------+----------------------------------------------------- var1 13.4923077.3545926.05 1.1 3 3 3 0.71 3 x 3 C 3 = 0.3579 2 1 0.71 2 x 0.29 x 3 C 2 = 0.4386
More informationDAA09
> summary(dat.lm1) Call: lm(formula = sales ~ price, data = dat) Residuals: Min 1Q Median 3Q Max -55.719-19.270 4.212 16.143 73.454 Coefficients: Estimate Std. Error t value Pr(> t ) (Intercept) 237.1326
More informationこんにちは由美子です
Prevalence (proportion) 1. 1991 23.8 2. 1960 52 85 2477 310 cross sectional study prevalence Time referent: prevalence 1985 40 45 prevalence 0.5 80 85 43 Time referent 1985 time referent Risk and Cumulative
More information食道がん化学放射線療法後のsalvage手術
2006 2 17 52 Daly JM, et al. J Am Coll Surg 2000;190:562-573 Esophageal Cancer: Results of an American College of Surgeons Patient Care Evaluation Study Daly JM, et al. J Am Coll Surg 2000;190:562-573
More information<30332D D8CB492982D FC95E490E690B62D8FAC8FBC96BE90E690B62E706466>
A questionnaire survey on the use of placebo in clinical practice by nurses in Japan 1 1 2 2 1 4 1964 5, 6 1998 GCP 1 School of Nursing, Faculty of Medicine, Toho University 2Faculty of Medical Technology,
More information層化
(confounding) Confounding Exposure? Outcome Confounders adjustment (confounders) Not Confounding? 2 exposure 3rd factor 3rd factor NEJM 2000; 342: 1930-6. (adjustment) univariate or crude relative risk
More informationkubostat2017b p.1 agenda I 2017 (b) probability distribution and maximum likelihood estimation :
kubostat2017b p.1 agenda I 2017 (b) probabilit distribution and maimum likelihood estimation kubo@ees.hokudai.ac.jp http://goo.gl/76c4i 2017 11 14 : 2017 11 07 15:43 1 : 2 3? 4 kubostat2017b (http://goo.gl/76c4i)
More information特 集 conditionally essential amino acid, グルタミンジペプチド (Glutamine dipeptide), 多臓器不全 Ⅰ はじめに sepsis RE- DOXS Ⅱ 重症患
143 特 集 conditionally essential amino acid, グルタミンジペプチド (Glutamine dipeptide), 多臓器不全 Ⅰ はじめに 1980 2013 sepsis RE- 173 8605 2 11 1 Ⅱ 重症患者における生体内でのグルタミンの役割 1950 Eagle 1 1970 2 1/3 40 50 144 30 conditionally
More informationk2 ( :35 ) ( k2) (GLM) web web 1 :
2012 11 01 k2 (2012-10-26 16:35 ) 1 6 2 (2012 11 01 k2) (GLM) kubo@ees.hokudai.ac.jp web http://goo.gl/wijx2 web http://goo.gl/ufq2 1 : 2 2 4 3 7 4 9 5 : 11 5.1................... 13 6 14 6.1......................
More informationStudies of Foot Form for Footwear Design (Part 9) : Characteristics of the Foot Form of Young and Elder Women Based on their Sizes of Ball Joint Girth
Studies of Foot Form for Footwear Design (Part 9) : Characteristics of the Foot Form of Young and Elder Women Based on their Sizes of Ball Joint Girth and Foot Breadth Akiko Yamamoto Fukuoka Women's University,
More information2 The Bulletin of Meiji University of Integrative Medicine 3, Yamashita 10 11
1-122013 1 2 1 2 20 2,000 2009 12 1 2 1,362 68.1 2009 1 1 9.5 1 2.2 3.6 0.82.9 1.0 0.2 2 4 3 1 2 4 3 Key words acupuncture and moxibustion Treatment with acupuncture, moxibustion and Anma-Massage-Shiatsu
More information4.9 Hausman Test Time Fixed Effects Model vs Time Random Effects Model Two-way Fixed Effects Model
1 EViews 5 2007 7 11 2010 5 17 1 ( ) 3 1.1........................................... 4 1.2................................... 9 2 11 3 14 3.1 Pooled OLS.............................................. 14
More information4703ALL01
473201010 *** (1999) 16 2017 20023 2 1 2 1220 (1999a),(1999b) (1998), (2002) (2003)(1999)(2003) Conjoint Analysis Conjoint Analysis Willingness to PayStandard gamble Time trade-off Rating Scale Willingness
More information1 Tokyo Daily Rainfall (mm) Days (mm)
( ) r-taka@maritime.kobe-u.ac.jp 1 Tokyo Daily Rainfall (mm) 0 100 200 300 0 10000 20000 30000 40000 50000 Days (mm) 1876 1 1 2013 12 31 Tokyo, 1876 Daily Rainfall (mm) 0 50 100 150 0 100 200 300 Tokyo,
More information第11回:線形回帰モデルのOLS推定
11 OLS 2018 7 13 1 / 45 1. 2. 3. 2 / 45 n 2 ((y 1, x 1 ), (y 2, x 2 ),, (y n, x n )) linear regression model y i = β 0 + β 1 x i + u i, E(u i x i ) = 0, E(u i u j x i ) = 0 (i j), V(u i x i ) = σ 2, i
More informationkubostat2017c p (c) Poisson regression, a generalized linear model (GLM) : :
kubostat2017c p.1 2017 (c), a generalized linear model (GLM) : kubo@ees.hokudai.ac.jp http://goo.gl/76c4i 2017 11 14 : 2017 11 07 15:43 kubostat2017c (http://goo.gl/76c4i) 2017 (c) 2017 11 14 1 / 47 agenda
More information日本統計学会誌, 第44巻, 第2号, 251頁-270頁
44, 2, 205 3 25 270 Multiple Comparison Procedures for Checking Differences among Sequence of Normal Means with Ordered Restriction Tsunehisa Imada Lee and Spurrier (995) Lee and Spurrier (995) (204) (2006)
More informationEAMS 2014
2014 2 10 RCT EAMS 2014 2015. 3. 31 Evidence Reports of Anma-Massage-Shiatsu: 2 Meta-Analisys and 10 Randomized Controlled Trials of Japan 31 Mar 2015 CONTENTS 1. (prologue).. 1 2. (steps for development
More informationuntitled
19 CSPOR CRC/2009.8.8-9 2009 8 8 ( ) - CSPOR CRC SEMINAR- twatanab@oncoloplan.com http://www.oncoloplan.com - Toru Watanabe MD - 2 Phase I: Dose Finding trial Phase II : Efficacy and Safety trial Phase
More information(lm) lm AIC 2 / 1
W707 s-taiji@is.titech.ac.jp 1 / 1 (lm) lm AIC 2 / 1 : y = β 1 x 1 + β 2 x 2 + + β d x d + β d+1 + ϵ (ϵ N(0, σ 2 )) y R: x R d : β i (i = 1,..., d):, β d+1 : ( ) (d = 1) y = β 1 x 1 + β 2 + ϵ (d > 1) y
More information% 10%, 35%( 1029 ) p (a) 1 p 95% (b) 1 Std. Err. (c) p 40% 5% (d) p 1: STATA (1). prtesti One-sample test of pr
1 1. 2014 6 2014 6 10 10% 10%, 35%( 1029 ) p (a) 1 p 95% (b) 1 Std. Err. (c) p 40% 5% (d) p 1: STATA (1). prtesti 1029 0.35 0.40 One-sample test of proportion x: Number of obs = 1029 Variable Mean Std.
More informationkubostat2018d p.2 :? bod size x and fertilization f change seed number? : a statistical model for this example? i response variable seed number : { i
kubostat2018d p.1 I 2018 (d) model selection and kubo@ees.hokudai.ac.jp http://goo.gl/76c4i 2018 06 25 : 2018 06 21 17:45 1 2 3 4 :? AIC : deviance model selection misunderstanding kubostat2018d (http://goo.gl/76c4i)
More informationStata11 whitepapers mwp-037 regress - regress regress. regress mpg weight foreign Source SS df MS Number of obs = 74 F(
mwp-037 regress - regress 1. 1.1 1.2 1.3 2. 3. 4. 5. 1. regress. regress mpg weight foreign Source SS df MS Number of obs = 74 F( 2, 71) = 69.75 Model 1619.2877 2 809.643849 Prob > F = 0.0000 Residual
More informationII) SIR SMR)
II) ) 6 55 95 95Confidence Interval; 95CI) confidence intervals 95 95 1 5 95CI.66 Mortality experience of cockpit crewmembers from Japan Airlines. Kaji M, Tango T, Asukata I, Tajima N, Yamamoto K, Yamamoto
More information2014ESJ.key
http://www001.upp.so-net.ne.jp/ito-hi/stat/2014esj/ Statistical Software for State Space Models Commandeur et al. (2011) Journal of Statistical Software 41(1) State Space Models in R Petris & Petrone (2011)
More informationkubo2015ngt6 p.2 ( ( (MLE 8 y i L(q q log L(q q 0 ˆq log L(q / q = 0 q ˆq = = = * ˆq = 0.46 ( 8 y 0.46 y y y i kubo (ht
kubo2015ngt6 p.1 2015 (6 MCMC kubo@ees.hokudai.ac.jp, @KuboBook http://goo.gl/m8hsbm 1 ( 2 3 4 5 JAGS : 2015 05 18 16:48 kubo (http://goo.gl/m8hsbm 2015 (6 1 / 70 kubo (http://goo.gl/m8hsbm 2015 (6 2 /
More informationR John Fox R R R Console library(rcmdr) Rcmdr R GUI Windows R R SDI *1 R Console R 1 2 Windows XP Windows * 2 R R Console R ˆ R
R John Fox 2006 8 26 2008 8 28 1 R R R Console library(rcmdr) Rcmdr R GUI Windows R R SDI *1 R Console R 1 2 Windows XP Windows * 2 R R Console R ˆ R GUI R R R Console > ˆ 2 ˆ Fox(2005) jfox@mcmaster.ca
More informationEBM Reviews Ovid Ovid EBM Reviews ACP Journal Club Cochrane Database of Systematic Revie
EBM Reviews 2006 4 Ovid http://www.usaco.co.jp/products/ovid/ovidplatform.html Ovid EBM Reviews ACP Journal Club Cochrane Database of Systematic Reviews CDSR Database of Abstracts of Reviews of Effectiveness
More information講義のーと : データ解析のための統計モデリング. 第5回
Title 講義のーと : データ解析のための統計モデリング Author(s) 久保, 拓弥 Issue Date 2008 Doc URL http://hdl.handle.net/2115/49477 Type learningobject Note この講義資料は, 著者のホームページ http://hosho.ees.hokudai.ac.jp/~kub ードできます Note(URL)http://hosho.ees.hokudai.ac.jp/~kubo/ce/EesLecture20
More information1999 02 03 Ver. 1.00 1999 07 09 Ver. 1.01 UID, 2003 10 01 Ver. 1.02 Storage SCU DICOM 3.0 Conformance Statement Ver.1.01 1999/07/09 1 0... 3 1... 3 1.1... 3 1.2... 3 1.3... 3 2... 4 2.1... 4 2.1.1... 4
More information自由集会時系列part2web.key
spurious correlation spurious regression xt=xt-1+n(0,σ^2) yt=yt-1+n(0,σ^2) n=20 type1error(5%)=0.4703 no trend 0 1000 2000 3000 4000 p for r xt=xt-1+n(0,σ^2) random walk random walk variable -5 0 5 variable
More informationX X X Y R Y R Y R MCAR MAR MNAR Figure 1: MCAR, MAR, MNAR Y R X 1.2 Missing At Random (MAR) MAR MCAR MCAR Y X X Y MCAR 2 1 R X Y Table 1 3 IQ MCAR Y I
(missing data analysis) - - 1/16/2011 (missing data, missing value) (list-wise deletion) (pair-wise deletion) (full information maximum likelihood method, FIML) (multiple imputation method) 1 missing completely
More informationAttendance Demand for J-League õ Shinsuke KAWAI* and Takeo HIRATA* Abstract The purpose of this study was to clarify the variables determining the attendance in J-league matches, using the 2,699 J-league
More informationuntitled
72 22 30 1985 Conductance Vessels flow Vessels< - Shear stress conductance vessel Exercise and Adenosine SPECT in the Patient with Angina SPECT,PET ACC/AHA/ASNC Guideline 2003 Dicarli JNM 2007;48:783
More information講義のーと : データ解析のための統計モデリング. 第3回
Title 講義のーと : データ解析のための統計モデリング Author(s) 久保, 拓弥 Issue Date 2008 Doc URL http://hdl.handle.net/2115/49477 Type learningobject Note この講義資料は, 著者のホームページ http://hosho.ees.hokudai.ac.jp/~kub ードできます Note(URL)http://hosho.ees.hokudai.ac.jp/~kubo/ce/EesLecture20
More informationSERPWatcher SERPWatcher SERP Watcher SERP Watcher,
SERPWatcher 112-8610 2-1-1 112-8610 2-1-1 229-8558 5-10-1 E-mail: nakabe@db.is.ocha.ac.jp, chiemi@is.ocha.ac.jp SERPWatcher SERP Watcher SERP Watcher, SERP Analysis of transition of ranking in SERP Watcher
More informationuntitled
WinLD R (16) WinLD https://www.biostat.wisc.edu/content/lan-demets-method-statistical-programs-clinical-trials WinLD.zip 2 2 1 α = 5% Type I error rate 1 5.0 % 2 9.8 % 3 14.3 % 5 22.6 % 10 40.1 % 3 Type
More informationJMP V4 による生存時間分析
V4 1 SAS 2000.11.18 4 ( ) (Survival Time) 1 (Event) Start of Study Start of Observation Died Died Died Lost End Time Censor Died Died Censor Died Time Start of Study End Start of Observation Censor
More information..,,...,..,...,,.,....,,,.,.,,.,.,,,.,.,.,.,,.,,,.,,,,.,,, Becker., Becker,,,,,, Becker,.,,,,.,,.,.,,
J. of Population Problems. pp.,,,.,.,,. Becker,,.,,.,,.,,.,,,,.,,,.....,,. ..,,...,..,...,,.,....,,,.,.,,.,.,,,.,.,.,.,,.,,,.,,,,.,,, Becker., Becker,,,,,, Becker,.,,,,.,,.,.,, ,,, Becker,,., Becker,
More information02[021-046]小山・池田(責)岩.indd
Developing a Japanese Enryo-Sasshi Communication Scale: Revising a Trial Version of a Scale Based on Results of a Pilot Survey KOYAMA Shinji and IKEDA Yutaka Toward exploring Japanese Enryo-Sasshi communication
More informationuntitled
18 1 2,000,000 2,000,000 2007 2 2 2008 3 31 (1) 6 JCOSSAR 2007pp.57-642007.6. LCC (1) (2) 2 10mm 1020 14 12 10 8 6 4 40,50,60 2 0 1998 27.5 1995 1960 40 1) 2) 3) LCC LCC LCC 1 1) Vol.42No.5pp.29-322004.5.
More information時間割引:双曲割引と弱加法性
Discussion aper No. 666 June 2006 The Institute of Social and Economic Research Osaka University 6-1 Mihogaoka, Ibaraki, Osaka 567-0047, Japan Time Discounting: Declining Impatience and Interval Effect
More information44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2)
(1) I 44 II 45 III 47 IV 52 44 4 I (1) ( ) 1945 8 9 (10 15 ) ( 17 ) ( 3 1 ) (2) 45 II 1 (3) 511 ( 451 1 ) ( ) 365 1 2 512 1 2 365 1 2 363 2 ( ) 3 ( ) ( 451 2 ( 314 1 ) ( 339 1 4 ) 337 2 3 ) 363 (4) 46
More informationi ii i iii iv 1 3 3 10 14 17 17 18 22 23 28 29 31 36 37 39 40 43 48 59 70 75 75 77 90 95 102 107 109 110 118 125 128 130 132 134 48 43 43 51 52 61 61 64 62 124 70 58 3 10 17 29 78 82 85 102 95 109 iii
More informationFig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo
Kekkaku Vol. 79, No. 1: 17-24, 2004 17 (Received 21 Aug. 2003/Accepted 18 Nov. 2003) Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly
More informationyamadaiR(cEFA).pdf
R 2012/10/05 Kosugi,E.Koji (Yamadai.R) Categorical Factor Analysis by using R 2012/10/05 1 / 9 Why we use... 3 5 Kosugi,E.Koji (Yamadai.R) Categorical Factor Analysis by using R 2012/10/05 2 / 9 FA vs
More information2
Programming of Terrestrial Broadcasters and BS Digital Broadcasters by Genre ABSTRACT This study examined the programming of terrestrial and BS digital broadcasters by genre from the viewpoint of economics,
More informationJournal Club 2017/05/30 Tomohiro Matsumoto PGY-2
Journal Club 2017/05/30 Tomohiro Matsumoto PGY-2 本 の論 March 21, 2017 2 Introduc)on 3 : (CIN) 3 25% 44µmol/L(0.5mg/dL) CIN 4 European Society of Urogenital Radiology. ESUR guidelines on contrast media,
More informationA5 PDF.pwd
Average Treatment Effect; ATE attributes Randomized Factorial Survey Experiment; RFSE cues ATE ATE Hainmueller et al. 2014 Average Marginal Component Effect ATE 67 4 2017 2 845 , ;, ATE, ;, ;, W 846 67
More informationSize Effect of Biomass on Carbonization Rate Treated in Superheated Steam Combined with Far Infrared Heating Akiko ISA Yoshio HAGURA and Kanichi Kit Graduate School of Biosphere Science, Hiroshima University,
More information1) University Group Diabetes Program: A study of hypoglycemic agents on vascular complica- in patients with adult-onset tions diabetes. I. Design, methods and baseline results. Diabetes 19 (suppl. 2):
More information29 Short-time prediction of time series data for binary option trade
29 Short-time prediction of time series data for binary option trade 1180365 2018 2 28 RSI(Relative Strength Index) 3 USD/JPY 1 2001 1 2 4 10 2017 12 29 17 00 1 high low i Abstract Short-time prediction
More information自殺の経済社会的要因に関する調査研究報告書
17 1 2 3 4 5 11 16 30,247 17 18 21,024 +2.0 6 12 13 WHO 100 14 7 15 2 5 8 16 9 10 17 11 12 13 14 15 16 17 II I 18 Durkheim(1897) Hamermesh&Soss(1974)Dixit&Pindyck(1994) Becker&Posner(2004) Rosenthal(1993)
More informationSEJulyMs更新V7
1 2 ( ) Quantitative Characteristics of Software Process (Is There any Myth, Mystery or Anomaly? No Silver Bullet?) Zenya Koono and Hui Chen A process creates a product. This paper reviews various samples
More informationk3 ( :07 ) 2 (A) k = 1 (B) k = 7 y x x 1 (k2)?? x y (A) GLM (k
2012 11 01 k3 (2012-10-24 14:07 ) 1 6 3 (2012 11 01 k3) kubo@ees.hokudai.ac.jp web http://goo.gl/wijx2 web http://goo.gl/ufq2 1 3 2 : 4 3 AIC 6 4 7 5 8 6 : 9 7 11 8 12 8.1 (1)........ 13 8.2 (2) χ 2....................
More informationGLM PROC GLM y = Xβ + ε y X β ε ε σ 2 E[ε] = 0 var[ε] = σ 2 I σ 2 0 σ 2 =... 0 σ 2 σ 2 I ε σ 2 y E[y] =Xβ var[y] =σ 2 I PROC GLM
PROC MIXED ( ) An Introdunction to PROC MIXED Junji Kishimoto SAS Institute Japan / Keio Univ. SFC / Univ. of Tokyo e-mail address: jpnjak@jpn.sas.com PROC MIXED PROC GLM PROC MIXED,,,, 1 1.1 PROC MIXED
More informationCOE-RES Discussion Paper Series Center of Excellence Project The Normative Evaluation and Social Choice of Contemporary Economic Systems Graduate Scho
COE-RES Discussion Paper Series Center of Excellence Project The Normative Evaluation and Social Choice of Contemporary Economic Systems Graduate School of Economics and Institute of Economic Research
More informationH22 BioS (i) I treat1 II treat2 data d1; input group patno treat1 treat2; cards; ; run; I
H BioS (i) I treat II treat data d; input group patno treat treat; cards; 8 7 4 8 8 5 5 6 ; run; I II sum data d; set d; sum treat + treat; run; sum proc gplot data d; plot sum * group ; symbol c black
More information日本製薬工業協会シンポジウム 生存時間解析の評価指標に関する最近の展開ー RMST (restricted mean survival time) を理解するー 2. RMST の定義と統計的推測 2018 年 6 月 13 日医薬品評価委員会データサイエンス部会タスクフォース 4 生存時間解析チー
日本製薬工業協会シンポジウム 生存時間解析の評価指標に関する最近の展開ー RMST (restricted mean survival time) を理解するー 2. RMST の定義と統計的推測 2018 年 6 月 13 日医薬品評価委員会データサイエンス部会タスクフォース 4 生存時間解析チーム 日本新薬 ( 株 ) 田中慎一 留意点 本発表は, 先日公開された 生存時間型応答の評価指標 -RMST(restricted
More informationJHN Journal Club 手稲渓仁会病院
JHOSPITALIST network GUIDE-IT trial; The Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure multicentre randomised clinical trial 20171010 1 70 (EF 30%), (PCI), (HbA1c
More information医学教育研究とは 2011_10_14 v1
- - how to overview - overview - - - - - Harden RM (1986). Medical Education, 20: 522-531 PBL Description: What was done? 64% Justification: Did it work? 29% Clarification: Why or how did it work 7% Cook
More informationAJACS18_ ppt
1, 1, 1, 1, 1, 1,2, 1,2, 1 1 DDBJ 2 AJACS3 2010 6 414:20-15:20 2231 DDBJ DDBJ DDBJ DDBJ NCBI (GenBank) DDBJ EBI (EMBL-Bank) GEO DDBJ Omics ARchive(DOR) ArrayExpress DTA (DDBJ Trace Archive) DRA (DDBJ
More informationⅠ. 緒言 Suzuki, et al., Ⅱ. 研究方法 1. 対象および方法 1 6 表 1 1, 調査票の内容 図
The Journal of the Japan Academy of Nursing Administration and Policies Vol 12, No 1, pp 515, 2008 原著 病棟勤務看護師の勤務状況とエラー ニアミスのリスク要因 Relationship between Risk Factors Related Medical Errors and Working Conditions
More information\\afs001-0m0005\project02\A32\M
Technical Information 2004.09 2009.04 Store Request Query Request Retrieve Request DICOM Client Application Remote SCP Remote Query/Retrieve SCP Image Stored * DICOM Server Application Remote SCU Print
More information5 Armitage x 1,, x n y i = 10x i + 3 y i = log x i {x i } {y i } 1.2 n i i x ij i j y ij, z ij i j 2 1 y = a x + b ( cm) x ij (i j )
5 Armitage. x,, x n y i = 0x i + 3 y i = log x i x i y i.2 n i i x ij i j y ij, z ij i j 2 y = a x + b 2 2. ( cm) x ij (i j ) (i) x, x 2 σ 2 x,, σ 2 x,2 σ x,, σ x,2 t t x * (ii) (i) m y ij = x ij /00 y
More information10_08.dvi
476 67 10 2011 pp. 476 481 * 43.72.+q 1. MOS Mean Opinion Score ITU-T P.835 [1] [2] [3] Subjective and objective quality evaluation of noisereduced speech. Takeshi Yamada, Shoji Makino and Nobuhiko Kitawaki
More informationIsogai, T., Building a dynamic correlation network for fat-tailed financial asset returns, Applied Network Science (7):-24, 206,
H28. (TMU) 206 8 29 / 34 2 3 4 5 6 Isogai, T., Building a dynamic correlation network for fat-tailed financial asset returns, Applied Network Science (7):-24, 206, http://link.springer.com/article/0.007/s409-06-0008-x
More informationuntitled
The Japanese Association for Behavior Analysis Newsletter, No. 35 The Japanese Association for Behavior Analysis Newsletter, No. 35 The Japanese Association for Behavior Analysis Newsletter, No. 35 Table
More informationStudy on Throw Accuracy for Baseball Pitching Machine with Roller (Study of Seam of Ball and Roller) Shinobu SAKAI*5, Juhachi ODA, Kengo KAWATA and Yu
Study on Throw Accuracy for Baseball Pitching Machine with Roller (Study of Seam of Ball and Roller) Shinobu SAKAI*5, Juhachi ODA, Kengo KAWATA and Yuichiro KITAGAWA Department of Human and Mechanical
More information181 第 54 回土木計画学研究発表会 講演集 GPS S-502W S-502W
181 GPS 1 2 3 4 1 98-845 468-1 S-52W E-mail: h-ymgc@plan.civil.tohoku.ac.jp 2 98-845 468-1 S-52W E-mail: mokmr@m.tohoku.ac.jp 3 18-626 2 15-3 C 6F E-mail: h kaneda@zenrin-datacom.net 4 18-626 2 15-3 C
More information生命倫理100_資料4-7
26 27 Single cell clones picked from swaps12p36 (18) Single cell clones picked from swaps12p18 (24) 1.3% (p0) 1.1% (p58) 28 29 Outline 30 31 32 33 34 Columbia, The New York Stem Cell Foundation Oocyte
More informationR Console >R ˆ 2 ˆ 2 ˆ Graphics Device 1 Rcmdr R Console R R Rcmdr Rcmdr Fox, 2007 Fox and Carvalho, 2012 R R 2
R John Fox Version 1.9-1 2012 9 4 2012 10 9 1 R R Windows R Rcmdr Mac OS X Linux R OS R R , R R Console library(rcmdr)
More informationyasi10.dvi
2002 50 2 259 278 c 2002 1 2 2002 2 14 2002 6 17 73 PML 1. 1997 1998 Swiss Re 2001 Canabarro et al. 1998 2001 1 : 651 0073 1 5 1 IHD 3 2 110 0015 3 3 3 260 50 2 2002, 2. 1 1 2 10 1 1. 261 1. 3. 3.1 2 1
More informationデジタルオルソ作成マニュアルに関する調査研究作業
A1-No.289 16 1 ...1....1....1....4...5...11... 11...16...16...16...18...22...24...26...29...31...31....31. (TIN)...31....31....31...41....41....43 . 14 20 IT. GZ-1 OR-1 1 1 1 2 2 2 3 A A B A a a a a 3
More informationこんにちは由美子です
Analysis of Variance 2 two sample t test analysis of variance (ANOVA) CO 3 3 1 EFV1 µ 1 µ 2 µ 3 H 0 H 0 : µ 1 = µ 2 = µ 3 H A : Group 1 Group 2.. Group k population mean µ 1 µ µ κ SD σ 1 σ σ κ sample mean
More information橡
TP T-13i AST ALT ALP Y CTP LOH CHE CRP 8.7 id 0.4 mg/d 21 AWL 131U/L 257 LU/L 12 111/L 234 11J/L 344 IU/L 0.30 mid No K a BUN ORE UA 142 meq/1 4.3 meqa 108 meqa 15.8 met! 0.71 mg/di 5.0 mg/d CEA 5_5 n8/m1
More informationIPSJ SIG Technical Report Vol.2009-BIO-17 No /5/26 DNA 1 1 DNA DNA DNA DNA Correcting read errors on DNA sequences determined by Pyrosequencing
DNA 1 1 DNA DNA DNA DNA Correcting read errors on DNA sequences determined by Pyrosequencing Youhei Namiki 1 and Yutaka Akiyama 1 Pyrosequencing, one of the DNA sequencing technologies, allows us to determine
More informationPresentation Title Goes Here
SAS 9: (reprise) SAS Institute Japan Copyright 2004, SAS Institute Inc. All rights reserved. Greetings, SAS 9 SAS 9.1.3 Copyright 2004, SAS Institute Inc. All rights reserved. 2 Informations of SAS 9 SAS
More information66-1 田中健吾・松浦紗織.pwd
Abstract The aim of this study was to investigate the characteristics of a psychological stress reaction scale for home caregivers, using Item Response Theory IRT. Participants consisted of 337 home caregivers
More informationuntitled
twatanab@oncoloplan.com http://www.oncoloplan.com I II - III IV Fig 3. Survival curves overall and according to response Bruzzi, P. et al. J Clin Oncol; 23:5117-5125 25 Copyright merican Society of Clinical
More information分布
(normal distribution) 30 2 Skewed graph 1 2 (variance) s 2 = 1/(n-1) (xi x) 2 x = mean, s = variance (variance) (standard deviation) SD = SQR (var) or 8 8 0.3 0.2 0.1 0.0 0 1 2 3 4 5 6 7 8 8 0 1 8 (probability
More informationKaplan-Meierプロットに付加情報を追加するマクロの作成
Kaplan-Meier 1, 2,3 1 2 3 A SAS macro for extended Kaplan-Meier plots Kengo Nagashima 1, Yasunori Sato 2,3 1 Department of Parmaceutical Technochemistry, Josai University 2 School of Medicine, Chiba University
More information36:378 第 38 回日本脳卒中学会講演シンポジウム 原著 36: , 要旨 TIA 2 t-pa Key words: stroke registry, stroke subtype, onset-visi
36:378 第 38 回日本脳卒中学会講演シンポジウム 原著 36: 378 384, 2014 1 2 要旨 1999 2012 10 31 29 26 80 30 TIA 2 t-pa Key words: stroke registry, stroke subtype, onset-visit time, chronological change はじめに 4 12 23 27 1 Japan
More information講義のーと : データ解析のための統計モデリング. 第2回
Title 講義のーと : データ解析のための統計モデリング Author(s) 久保, 拓弥 Issue Date 2008 Doc URL http://hdl.handle.net/2115/49477 Type learningobject Note この講義資料は, 著者のホームページ http://hosho.ees.hokudai.ac.jp/~kub ードできます Note(URL)http://hosho.ees.hokudai.ac.jp/~kubo/ce/EesLecture20
More informationkubostat7f p GLM! logistic regression as usual? N? GLM GLM doesn t work! GLM!! probabilit distribution binomial distribution : : β + β x i link functi
kubostat7f p statistaical models appeared in the class 7 (f) kubo@eeshokudaiacjp https://googl/z9cjy 7 : 7 : The development of linear models Hierarchical Baesian Model Be more flexible Generalized Linear
More information